Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMichigan State University

About this trial

The goal of this clinical trial is to learn if culturally targeted messaging about the human papillomavirus (HPV) increases receptivity to the HPV vaccine among African American parents of vaccine-eligible daughters. The main question it aims to answer is:

• Does culturally targeted messaging increase African American parents' intentions to vaccinate their daughter against HPV?

Research will compare culturally targeted messaging to general, educational messaging and no messaging.

Participants will:

* View culturally targeted messages, education-only messages, or no messages about the HPV vaccine * Report their intentions to vaccinate their daughter against HPV * Report whether they have initiated HPV vaccination for their daughter six months later

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Identify as Black/African American or White/Caucasian

Have at least one daughter who is between 8-17 years of age, who is not currently pregnant, and who has not received any doses of the HPV vaccine

Disqualifiers

N/A

Trial design

Design model

Parallel

Treatments tested in this trial

  • General HPV Vaccine Health Messaging

    Behavioral

    General, education-only messaging about the HPV vaccine does not include culturally targeted messaging.

  • Culturally Targeted HPV Vaccine Health Messaging

    Behavioral

    Educational messaging about the HPV vaccine includes culturally targeted messaging about the HPV vaccine.

Treatment groups

265 Participants
are divided into 5 treatment groups
Group A: African American Culturally Targeted MessagingExperimental treatment 1 intervention
Group B: African American General, Education-Only MessagingActive comparator 1 intervention
Group C: African American No MessageNo intervention 0 interventions
Group D: White General, Education-Only MessagingActive comparator 1 intervention
Group E: White No MessageNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

HPV Vaccine Attitudes

Subscale of Theory of Planned Behavior measuring attitudes toward the HPV vaccine on response scale ranging from 1 = Strongly disagree to 7 = Strongly agree, where higher average scores indicate more positive attitudes

Time frame
Immediately following and 6-months post-health messaging
2

HPV Vaccine Normative Beliefs

Subscale of Theory of Planned Behavior measuring the extent to which participants believe other people are favorable toward the HPV vaccine on response scale ranging from 1 = Strongly disagree to 7 = Strongly agree, where higher average scores indicate stronger normative beliefs

Time frame
Immediately following and 6-months post-health messaging
3

HPV Vaccine Perceived Behavioral Control

Subscale of Theory of Planned Behavior measuring beliefs about ability to vaccinate their child on response scale ranging from 1 = Strongly disagree to 7 = Strongly agree, where higher average scores indicate greater perceived behavioral control

Time frame
Immediately following and 6-months post-health messaging
4

HPV Vaccine Intentions

Subscale of Theory of Planned Behavior measuring intentions to vaccinate their child on response scale ranging from 1 = Strongly disagree to 7 = Strongly agree, where higher average scores indicate greater intentions

Time frame
Immediately following and 6-months post-health messaging

Secondary outcomes

1

Anticipatory Racism

3 items measuring the extent to which parents expect racism-related factors to interfere with getting the HPV vaccine for their daughter on a 7-point response scale on response scale ranging from 1 = Strongly disagree to 7 = Strongly agree, where higher average scores indicate greater expectations of racism

Time frame
Immediately following health messaging

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.